Effect of sodium-glucose co-transporter-2 inhibitors on survival free of organ support in patients hospitalised for COVID-19 (ACTIV-4a): a pragmatic, multicentre, open-label, randomised, controlled, platform trial - Kosiborod, Mikhail N; Windsor, Sheryl L; Vardeny, Orly; Berger, Jeffrey S; Reynolds, Harmony R; Boumakis, Stavroula; Althouse, Andrew D; Solomon, Scott D; Bhatt, Ankeet S; Peikert, Alexander; Luther, James F; Leifer, Eric S; et al. (Lancet Diabetes & Endocrinology, 2024)